Peritoneal dialysis system

• US 8,696,613 B2
• Filed: 11/02/2011
• Issued: 04/15/2014
• Est. Priority Date: 02/08/2006
• Status: Active Grant

• Current Assignee: Debiotech S.A.
• Original Assignee: Debiotech S.A.
• Inventors: Quarteroni, Alfio, Mastalli, Diego, Zunino, Paolo
• Primary Examiner(s): SCHMIDT, EMILY LOUISE
• Application Number:
  US13/287,939
• Publication Number:
  US 20120143124A1
• Time in Patent Office: 895 Days
• Field of Search: 604/29, 604/500, 600/301
• US Class Current: 604/29
• CPC Class Codes: A61M 1/28 Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
• CPC Class Codes: A61M 1/282 Operational modes
• CPC Class Codes: A61M 2205/33 Controlling, regulating or measuring
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Abstract

The invention relates to a method for prescribing a dialysis treatment comprising the following steps:

• • collecting patient specific data,
  • determining at least one target,
  • defining a series of values of the type [V;t] which allow to achieve said target wherein V represents the volume of dialysate used and t the duration of treatment, based on said patient specific data,
  • displaying said series of values on a map.

The invention also relates to a system using this method.

Claims

1. A method for prescribing a dialysis treatment comprising the following steps:

collecting patient specific data,

determining at least one target,

defining a series of values of the type [V;

t] which allow to achieve said target wherein V represents the volume of dialysate used and t the duration of treatment, based on said patient specific data,

displaying said series of values on a map.

2. The method according to claim 1, whereby the dialysis is a peritoneal dialysis.

3. The method according to claim 2, wherein said target is taken from the followings:

Ultra-filtration, sodium removal or glucose absorption.

4. The method according to claim 2, wherein said target is a clearance of a solute taken from creatinine, urea, or microglobuline.

5. The method according to claim 1, wherein said series of values is displayed in the form of a continuous curve in an orthogonal bi-dimensional graph.

6. The method according to claim 5, which includes the displaying of several series of a values on a map, each series corresponding to a specific target value and defining an isoline on said graph.

7. The method according to claim 1, wherein the patient specific data are obtained by a test, such as PET, PDC miniPET or other dialysis tests able to calculate the patient peritoneal membrane characteristics.

8. The method according to claim 1, wherein additional information related to at least another patient specific parameter are provided on the map.

9. The method according to claim 8, wherein said other parameter is taken from the followings:

sodium removal, glucose absorption, ultra-filtration, protein intake, microglobuline clearance, effect on diet and kidney function.

20. The method according to claim 8, wherein the additional information related to at least another patient specific parameter is provided in a background of the map.

10. A peritoneal dialysis prescription system comprising:

a first processor for entering patient specific data,

a second processor for selecting a target,

a third processor for defining a series of values of the type [V;

t] which allow to achieve said target wherein V represents the volume of dialysate used and t the duration of treatment,

a display adapted for displaying said series of values on a map.

11. The peritoneal dialysis prescription system according to claim 10, wherein said display is adapted to represent said series of values in the form of a continuous curve in an orthogonal bi-dimensional graph.

12. The peritoneal dialysis prescription system according to claim 11, wherein said display is adapted to represent several series of values on a map, each series corresponding to a specific target and defining an isoline on said graph.

13. The peritoneal dialysis prescription system according to claim 11, wherein said target is taken from the followings:

Ultra-filtration, sodium removal or glucose absorption.

14. The peritoneal dialysis prescription system according to claim 11, wherein said target is a clearance of a solute taken from the followings:

creatinine, urea or microglobuline.

15. The peritoneal dialysis prescription system according to claim 11, wherein the patient specific data are obtained by a test, such as PET, PDC miniPET or other dialysis tests able to calculate the patient membrane characteristics.

16. The peritoneal dialysis prescription system according to claim 11, wherein additional information related to at least another patient specific parameter are provided on the map.

17. The peritoneal dialysis prescription system according to claim 16, wherein said other parameter is taken from the followings:

sodium removal, glucose absorption, ultra-filtration, protein intake, microglobuline clearance, effect on diet and kidney function.

18. The peritoneal dialysis prescription system according to claim 11, comprising a second display for displaying the treatment parameters and the expected results for any of said series of values.

19. The peritoneal dialysis prescription system according to claim 11, furthermore comprising automatic parameter recording means which are adapted to automatically record the selected treatment parameters.

21. The peritoneal dialysis prescription system according to claim 16, wherein the additional information related to at least another patient specific parameter is provided in a background of the map.